THE SGLT2 INHIBITOR DAPAGLIFLOZIN IMPROVES ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE STUDY

被引：0
|
作者：
Cannarella, Rossella [1 ]
Condorelli, Rosita A. Angela [2 ]
Leanza, Claudia [2 ]
Garofalo, Vincenzo [2 ]
Lundy, Scott [3 ]
Calogero, Aldo E. [4 ]
La Vignera, Sandro [2 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Univ Catania, Dept Clin & Expt Med, Catania, Italy
[3] Cleveland Clin Fdn, Cleveland, OH USA
[4] Univ Catania, Catania, CT, Italy
来源：
FERTILITY AND STERILITY | 2023年 / 120卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-342
引用
收藏
页码：E245 / E246
页数：2
相关论文
共 50 条
  • [1] The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus
    Sugiyama, Seigo
    Jinnouchi, Hideaki
    Kurinami, Noboru
    Hieshima, Kunio
    Yoshida, Akira
    Jinnouchi, Katsunori
    Nishimura, Hiroyuki
    Suzuki, Tomoko
    Miyamoto, Fumio
    Kajiwara, Keizo
    Jinnouchi, Tomio
    INTERNAL MEDICINE, 2018, 57 (15) : 2147 - 2156
  • [2] DAPAGLIFLOZIN, AN SGLT2 INHIBITOR FOR THE TREATMENT OF TYPE 2 DIABETES
    Demaris, K. M.
    White, J. R.
    DRUGS OF TODAY, 2013, 49 (05) : 289 - 301
  • [3] Dapagliflozin, an SGLT2 inhibitor, for diabetes
    Hanefeld, Markolf
    Forst, Thomas
    LANCET, 2010, 375 (9733): : 2196 - 2198
  • [4] Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
    Yavin, Yshai
    Mansfield, Traci A.
    Ptaszynska, Agata
    Johnsson, Kristina
    Parikh, Shamik
    Johnsson, Eva
    DIABETES THERAPY, 2016, 7 (01) : 125 - 137
  • [5] Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
    Yshai Yavin
    Traci A. Mansfield
    Agata Ptaszynska
    Kristina Johnsson
    Shamik Parikh
    Eva Johnsson
    Diabetes Therapy, 2016, 7 : 125 - 137
  • [6] Safety and efficacy of the SGLT2 inhibitor dapagliflozin in older patients with type 2 diabetes
    Fioretto, P.
    de Bruin, T. W.
    Johnsson, E.
    Ptaszynska, A.
    Parikh, S.
    List, J. F.
    DIABETOLOGIA, 2013, 56 : S383 - S383
  • [7] A Prospective Observational Study to Assess the Efficacy of a SGLT2 Inhibitor (Dapagliflozin) in Kidney Allograft Recipients with Diabetes Mellitus
    Naskar, Avishek
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [8] Treatment with SGLT2 inhibitor dapagliflozin for non-alcoholic steatohepatitis patients complicated with type 2 diabetes mellitus
    Tobita, Hiroshi
    Sato, Shuiti
    Miyake, Tatuya
    Yazaki, Tomotaka
    Isoda, Kazuki
    Mishiro, Tuyoshi
    Ishihara, Shunji
    Kinoshita, Yoshikazu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 388 - 388
  • [9] Targeting Renal Glucose Reabsorption for the Treatment of Type 2 Diabetes Mellitus Using the SGLT2 Inhibitor Dapagliflozin
    Jabbour, Serge A.
    Whaley, Jean M.
    Tirmenstein, Mark
    Poucher, Simon M.
    Reilly, Timothy P.
    Boulton, David W.
    Saye, JoAnne
    List, James F.
    Parikh, Shamik
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 62 - 73
  • [10] DAPAGLIFLOZIN, A SELECTIVE SGLT2 INHIBITOR, IMPROVED GLYCEMIC CONTROL OVER 2 WEEKS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
    Kasichayanula, S.
    Griffen, S. C.
    Chalamandaris, A.
    LaCreta, F.
    Boulton, D. W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S19 - S20
12345